Spiriva capsules contain 18 mcg of tiotropium and are light green, with the Boehringer Ingelheim company logo on the Spiriva capsule cap and TI 01 on the Spiriva capsule body, or vice versa.

In a question and answer session at the company's annual results conference in Germany today, managing director Hubertus von Baumbach noted that Spiriva's patent had expired in the US. But he said ...

Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO. Formerly the company's chief finance officer, Hubertus von Baumbach has been in ...

Much like Nifty companies, pharma giants are now facing a slowdown in earnings growth. After enjoying a joyride through FY24, posting record revenues quarter after quarter, several pharma companies ...

Tiotropium (as bromide monohydrate) 1.25mcg, 2.5mcg; per actuation; inh spray; contains benzalkonium chloride. Spiriva Respimat Inhalation Spray is supplied in a carton containing one Spiriva ...

Boehringer Ingelheim is also planning to cut the list prices for Spiriva HandiHaler and Atrovent HFA ... medicines including an ongoing commitment to responsible pricing,” a company spokesperson said.

The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%.

The company replaced them with "authorized generic ... The cap applies to its Atrovent HFA, Combivent Respimat and Spiriva ...

Bain & Company's consultants provide management advice from 64 offices in 39 countries. Founded in 1973 in Boston, Bain & Co. has evolved into one of the big three management-consulting firms ...

“While 61% of co-buyers are buying with a spouse or significant other, 16% are buying with parents and 11% are buying with friends,” he explains. Men are more likely to purchase a home with a ...

Co-op housing provides an alternative to the traditional methods of acquiring a primary residence. A housing cooperative or "co-op" is a type of residential housing option that is actually a ...

But the YoY growth is expected to decline for the Indian Pharmaceutical Market (IPM), projected at approximately 8 per cent, ...